Alpha 2.0
Login Register
» Articles » PMID: 18764910

Autologous Peripheral Blood Stem-cell Transplantation with a Double-conditioning Regimen for Recurrent Hepatoblastoma After Liver Transplantation--a Valid Therapeutic Option or Just Too Much?

Overview
Journal Pediatr Transplant
Specialty Pediatrics
Date 2008 Sep 4
PMID 18764910
Citations 6
Authors
Giorgio Perilongo
Jean Bernard Otte
Affiliations
Soon will be listed here.
Citing Articles

Retreatment with Cisplatin May Provide a Survival Advantage for Children with Relapsed/Refractory Hepatoblastoma: An Institutional Experience.

Somers K, Tabbouche R, Bondoc A, Towbin A, Ranganathan S, Tiao G Cancers (Basel). 2023; 15(15).

PMID: 37568737 PMC: 10416880. DOI: 10.3390/cancers15153921.

How Do Synchronous Lung Metastases Influence the Surgical Management of Children with Hepatoblastoma? An Update and Systematic Review of the Literature.

Angelico R, Grimaldi C, Gazia C, Saffioti M, Manzia T, Castellano A Cancers (Basel). 2019; 11(11).

PMID: 31683629 PMC: 6895839. DOI: 10.3390/cancers11111693.

Unresectable hepatoblastoma: current perspectives.

Trobaugh-Lotrario A, Meyers R, ONeill A, Feusner J Hepat Med. 2017; 9:1-6.

PMID: 28203111 PMC: 5293365. DOI: 10.2147/HMER.S89997.

Targeting EpCAM (CD326) for immunotherapy in hepatoblastoma.

Armeanu-Ebinger S, Hoh A, Wenz J, Fuchs J Oncoimmunology. 2013; 2(1):e22620.

PMID: 23482411 PMC: 3583930. DOI: 10.4161/onci.22620.

Several important in vitro improvements in the amplification, differentiation and tracing of fetal liver stem/progenitor cells.

Liu W, Liu Z, You N, Zhang N, Wang T, Gong Z PLoS One. 2012; 7(10):e47346.

PMID: 23056632 PMC: 3467257. DOI: 10.1371/journal.pone.0047346.